Expert Roundtable – Utility of liquid biopsies and solid tumor MRD in clinical trials

Liquid biopsies have significant potential to impact clinical trials and a large number of studies are in progress to prove clinical utility. 

REGISTER BELOW to watch leading European KOLs discuss the current and future use of liquid biopsies and some success stories in clinical trials:

No cost to register;  subject to confirmation. 
By registering for this event, you accept that you may receive direct communication from the sponsor(s).
If you are experiencing problems with your registration, please try the Zoom registration page.

Chris Abbosh

Medical Oncology Clinician Scientist, UCL

Overview of the solid tumor MRD landscape

Thomas Powles

Director, Barts Cancer Center

IMvigor trial

Angel Rodriguez

Medical Director, Oncology, Natera

Tumor-informed MRD testing across cancer types

Naureen Starling

Principal Investigator, Royal Marsden Hospital

Liquid biopsies for faster diagnosis

  • Overview of the solid tumor MRD landscape
  • Liquid biopsies for faster diagnosis
  • Success story and data in clinical trials – IMvigor
  • Tumor-informed MRD testing across tumor types

 Developed by Endpoints Studio © 2021